CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Raises Price Target on Disc Medicine to $100 From $88, Keeps Outperform Rating

Positive
AI Analysis

Summary

Wedbush raised its price target on Disc Medicine to $100 from $88 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.40
price_target_increaseanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on September 2, 2026 11:03 AM

Read Original